Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 797

Results For "ED"

9527 News Found

Live Pharma Coalition to organise its first-ever conclave in Mumbai
News | March 15, 2022

Live Pharma Coalition to organise its first-ever conclave in Mumbai

The focus is to build collaborative learning and sharing ecosystem


IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
People | March 15, 2022

IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster

He has over 25 years of rich experience in marketing and business in various sectors


Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
Biotech | March 15, 2022

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals

A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


USFDA approves Zydus’ Colestipol Hydrochloride tablets
Drug Approval | March 14, 2022

USFDA approves Zydus’ Colestipol Hydrochloride tablets

It is only the second generic application approved by the USFDA


Alembic receives USFDA tentative approval for hypertension drug
Drug Approval | March 14, 2022

Alembic receives USFDA tentative approval for hypertension drug

Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA


SPAG appoints Ritika Jauhari as President- Strategy & New Business
People | March 14, 2022

SPAG appoints Ritika Jauhari as President- Strategy & New Business

Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


Guardant Health receives regulatory approval for Guardant360 CDx in Japan
Medical Device | March 14, 2022

Guardant Health receives regulatory approval for Guardant360 CDx in Japan

Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers


Illumina and Trivitron collaborate for next-generation sequencing in India
Medical Device | March 14, 2022

Illumina and Trivitron collaborate for next-generation sequencing in India

In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches